Pancreatic Cancer Research

ResearcherNanjing University of Chinese MedicineNo recent work listed

Yang Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6993-4870; OpenAlex author ID A5100350365. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2019: 2 papers · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 3

  1. Immune response and drug therapy based on ac4C-modified gene in pancreatic cancer typing. Co-author DOI 10.3389/fimmu.2023.1133166↗
  2. CA19-9 decrease and survival according to platelet level in patients with advanced pancreatic cancer. Co-author DOI 10.1186/s12885-019-6078-2↗
  3. Preoperative CA19-9 levels predict disease-free survival and overall survival in pancreatic adenocarcinoma patients after resection. First author DOI 10.21037/tcr.2019.04.24↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Guanghai Dai · 2 shared papers, 2019 · strength 0.24
  2. Cunbing Xia · 1 shared paper, 2023 · strength 0.22
  3. Hongbao Yang · 1 shared paper, 2023 · strength 0.22
  4. Dong Xu · 1 shared paper, 2023 · strength 0.22
  5. Quanli Han · 1 shared paper, 2019 · strength 0.11
  6. Guochao Deng · 1 shared paper, 2019 · strength 0.11
  7. Shasha Guan · 1 shared paper, 2019 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.